Evidence map›Paper›PMID 33130819›Full record

ReviewBone marrow transplantation2021

Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation.

Guilherme H Oliveira, Sadeer G Al-Kindi, Avirup Guha, Amit K Dey, Isaac B Rhea, Marcos J deLima

Abstract readReview
PubMed Publisher
In one paragraph

Review in Bone marrow transplantation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Coronary Revascularization in Patients With Cancer.Current treatment options in cardiovascular medicine · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guilherme H Oliveira *Heart and Vascular Institute, University of South Florida, Tampa General Hospital and Moffitt Cancer Center, Tampa, FL, USA. oliveirag@usf.edu.
Sadeer G Al-Kindi *University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Avirup GuhaUniversity Hospitals Cleveland Medical Center, Cleveland, OH, USA.ORCID http://orcid.org/0000-0003-0253-1174
Amit K DeyNational Heart, Lung and Blood Institute, Bethesda, MD, USA.
Isaac B RheaDivision of Cardiovascular Diseases, University of Tennessee Health Science Center, Memphis, TN, USA.
Marcos J deLimaDepartment of Medicine, Case Western Reserve University, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-8568-4522

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this review is to provide a framework for the cardiovascular evaluation and management of patients undergoing hematopoietic cell transplantation (HCT). To accomplish this, we have performed an extensive literature review, critically analyzed the available evidence, and developed a set of recommendations to guide best practice. Herein, we discuss the cardiovascular risk profile of patients undergoing HCT along with putative mechanisms of HCT-induced cardiovascular injury. We then present an algorithm for cardiovascular testing and risk mitigation of potential recipients. Last, we address the management of the most prevalent cardiovascular conditions associated with HCT recipients.

Indexed as

Cardiovascular DiseasesHematopoietic Stem Cell TransplantationHeart Disease Risk FactorsHumansRisk AssessmentRisk Factors

Identifiers

PMID33130819

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.